# FDA 483 - J. Scott Ferguson, MD - November 22, 2024

Source: https://www.keypedia.com/records/483/j-scott-ferguson-md/d3dcc21e-3bc3-4181-ab1f-1f677bc85219

> FDA 483 for J. Scott Ferguson, MD on November 22, 2024. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: J. Scott Ferguson, MD
- Inspection Date: 2024-11-22
- Product Type: other
- Office Name: Minneapolis District Office
- Summary: An FDA inspection of J. Scott Ferguson, MD in Madison, WI, a clinical investigator, revealed that an investigation for the SPRAY-CB study was not conducted in accordance with the signed agreement, investigational plan, and applicable FDA regulations. Specifically, under-performing catheters were not returned to the sponsor for evaluation, and data integrity was compromised as the study coordinator completed subject questionnaires instead of the subjects themselves.

## Related Officers

- [Bioresearch Monitoring Specialis](https://www.keypedia.com/people/denise-l-burosh/075a442f-67e0-4a65-9c09-e8819a329773)

Company: https://www.keypedia.com/companies/j-scott-ferguson-md/64389736-96e6-4dc4-9bfa-02789b6da729

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d